900m lives depend on livestock

GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline

About GALVmed

More than 9 million square km of Africa is affected by the devastating disease that affects cattle - Animal African Trypanosomosis.

GALVmed works with 31 partners to produce new trypanocide that will reduce the severe economic impact on African livestock keepers and the disease’s prevalance.

Screening for 4,693 of molecules for a new trypanocide is currently undergoing.

Discover our Tryps developments

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Market development

Our work with our partners supports the poor livestock keepers of the world.

Policy and advocacy

The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.


Galvanising action against Newcastle Disease in Tanzania

Since 2011, low income rural farmers in Babati district in Tanzania, who rear indigenous chickens to supplement their livelihoods are seeing the significant benefits of having improved access to the I-2 Newcastle Disease (ND) vaccine to protect …

Recognising the vital role of community animal health workers

After seeing a poster advertising training, 30-year-old Jayanti Mohanta (not pictured) contacted an NGO implementing GALVmed’s Newcastle disease control project, BMPCS, in Baripada, Mayurbhanj district, India to become a community animal health worker (CAHW).

In her …

East Coast Fever vaccine saves cattle and cost

Livestock keepers and vaccinators discuss how the Muguga Cocktail “one shot for life” East Coast Fever vaccine is being used in Kenya.

Produced by WRENmedia.

Filmed by Pius Sawa, WRENmedia correspondent.